End of phase I results of ZUMA-3, a phase 1/2 study of KTE-X19, anti-CD19 chimeric antigen receptor (CAR) T cell therapy, in adult patients (pts) with relapsed/refractory (R/R) acute lymphoblastic leukemia (ALL) Meeting Abstract
| Authors: | Shah, B. D.; Bishop, M. R.; Oluwole, O. O.; Logan, A.; Baer, M. R.; Donnellan, W. B.; Carr-O'Dwyer, K. M.; Holmes, H.; Arellano, M. L.; Ghobadi, A.; Pagel, J. M.; Lin, Y.; Cassaday, R. D.; Park, J. H.; Mardiros, A.; Shen, T.; Goyal, L.; Vezan, R.; Jain, R. K.; Wierda, W. G. |
| Abstract Title: | End of phase I results of ZUMA-3, a phase 1/2 study of KTE-X19, anti-CD19 chimeric antigen receptor (CAR) T cell therapy, in adult patients (pts) with relapsed/refractory (R/R) acute lymphoblastic leukemia (ALL) |
| Meeting Title: | 55th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 37 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2019 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2019-05-20 |
| Start Page: | 407s |
| Language: | English |
| ACCESSION: | WOS:000487345806209 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2019.37.15_suppl.7006 |
| Notes: | Meeting Abstract: 7006 -- Source: Wos |
